SCHEMBL7739003

SCHEMBL7739003

O=C(Nc1oc(-c2ccc(-c3cccc([N+](=O)[O-])c3)cc2O)nc1C1=CC(=S)CC=C1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPN P05981 1/20 0.44
HDAC2 Q92769 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 3/20 0.39
MAPT P10636 6/20 0.38
HTT P42858 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP2 O95551 2/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
ABCB1 P08183 1/20 0.36
ABCC1 P33527 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746568 0.91 KDR (0.41) HDAC2ABCG2KMT2AALDH1A1MEN1
SCHEMBL7739072 0.90 KDR (0.43) HPNABCG2MAPTKDM4ESMN1; SMN2
SCHEMBL7986526 0.88 KDR (0.42) HDAC2KMT2AALDH1A1MEN1MAPT
SCHEMBL7969457 0.88 KDR (0.42) KMT2AMEN1MAPTHTTCYP1A2
SCHEMBL7986013 0.86 KDR (0.39) HDAC2KMT2AALDH1A1MEN1MAPT
SCHEMBL7746563 0.85 HDAC2 (0.53) HPNHDAC2ABCG2KMT2AALDH1A1
SCHEMBL7746645 0.85 HPN (0.39) HPNHDAC2KMT2AALDH1A1MEN1
SCHEMBL7969509 0.84 MCL1 (0.38) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL7980106 0.84 KDR (0.42) HDAC2ABCG2KMT2AALDH1A1MEN1
SCHEMBL7744761 0.83 HPN (0.46) HPNHDAC2ABCG2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed